The Filing Desk

Fortress Biotech vs Nuvation Bio

Fortress Biotech FBIO · Nuvation Bio NUVB · Pharmaceuticals

Fortress Biotech reported revenue of $63 million in fiscal 2025, about the same as Nuvation Bio's $63 million in fiscal 2025. Fortress Biotech's revenue grew 9.7% in its latest year, and Nuvation Bio's grew 699.0%. Fortress Biotech had an operating margin of -111.0%, against -338.7% at Nuvation Bio.

Side by side

Fortress BiotechNuvation Bio
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$63M$63M
Revenue growth9.7%699.0%
Revenue growth a year, last 5 years6.8%—
Gross margin66.9%—
Operating margin−111.0%−338.7%
Net margin10.8%−325.3%
Free cash flow—−$181M
Free cash flow margin—−288.4%
Return on capital−323.7%—
Net debt to EBITDA——
Dividends and buybacks$1M$0M
Change in diluted share count34.2%27.1%
Last close$1.77$3.81
P/E at the last close——
Insider trades, last 12 monthsbought $340,398, sold $0bought $118,250, sold $7.6 million
Piotroski F-score6 of 9—
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
Fortress BiotechNuvation Bio
Operating margin
Percent of revenue
Fortress BiotechNuvation Bio
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Fortress BiotechNuvation Bio

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Fortress Biotech and Nuvation Bio pages.